
The U.S. panel also plans to retreat from its 2016 recommendation to take baby aspirin for the prevention of colorectal cancer, guidance that was groundbreaking at the time. The panel said that more recent data had raised questions about the putative benefits for cancer, and that more research was needed.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/30me7bR
via
IFTTT
0 comments:
Post a Comment